KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Depreciation and Depletion: 2014-2020

Historic Depreciation and Depletion for Palvella Therapeutics (PVLA) over the last 6 years, with Jun 2020 value amounting to $530,000.

  • Palvella Therapeutics' Depreciation and Depletion rose 1161.90% to $530,000 in Q2 2020 from the same period last year, while for Jun 2020 it was $1.3 million, marking a year-over-year increase of 136.59%. This contributed to the annual value of $1.8 million for FY2023, which is 21.74% down from last year.
  • Per Palvella Therapeutics' latest filing, its Depreciation and Depletion stood at $530,000 for Q2 2020, which was up 56.34% from $339,000 recorded in Q1 2020.
  • Palvella Therapeutics' Depreciation and Depletion's 5-year high stood at $530,000 during Q2 2020, with a 5-year trough of -$11,764 in Q2 2016.
  • In the last 3 years, Palvella Therapeutics' Depreciation and Depletion had a median value of $162,500 in 2019 and averaged $206,900.
  • Per our database at Business Quant, Palvella Therapeutics' Depreciation and Depletion crashed by 115.39% in 2016 and then soared by 1,161.90% in 2020.
  • Over the past 5 years, Palvella Therapeutics' Depreciation and Depletion (Quarterly) stood at $224,613 in 2016, then plummeted by 41.23% to $132,000 in 2017, then spiked by 47.73% to $195,000 in 2018, then increased by 19.49% to $233,000 in 2019, then skyrocketed by 1,161.90% to $530,000 in 2020.
  • Its Depreciation and Depletion was $530,000 in Q2 2020, compared to $339,000 in Q1 2020 and $233,000 in Q4 2019.